82 related articles for article (PubMed ID: 8389559)
1. Immunological parameters during treatment with ditiocarb (Imuthiol).
Vanham GL; Kestens L; Van Hoof J; Penne G; Colebunders R; Goilav C; Vandenbruaene M; el Habib R; Gigase P
AIDS; 1993 Apr; 7(4):525-30. PubMed ID: 8389559
[TBL] [Abstract][Full Text] [Related]
2. Expansion of CD57 and CD62L-CD45RA+ CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection.
Lieberman J; Trimble LA; Friedman RS; Lisziewicz J; Lori F; Shankar P; Jessen H
AIDS; 1999 May; 13(8):891-9. PubMed ID: 10371169
[TBL] [Abstract][Full Text] [Related]
3. Multicenter, randomized, placebo-controlled study of ditiocarb (Imuthiol) in human immunodeficiency virus-infected asymptomatic and minimally symptomatic patients. The HIV87 Study Group.
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):83-9. PubMed ID: 8094001
[TBL] [Abstract][Full Text] [Related]
4. Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages.
Janossy G; Borthwick N; Lomnitzer R; Medina E; Squire SB; Phillips AN; Lipman M; Johnson MA; Lee C; Bofill M
AIDS; 1993 May; 7(5):613-24. PubMed ID: 8318170
[TBL] [Abstract][Full Text] [Related]
5. T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS.
Levacher M; Tallet S; Dazza MC; Dournon E; Rouveix B; Pocidalo JJ
Clin Exp Immunol; 1990 Aug; 81(2):177-82. PubMed ID: 1696859
[TBL] [Abstract][Full Text] [Related]
6. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28- T cells.
Borthwick NJ; Bofill M; Gombert WM; Akbar AN; Medina E; Sagawa K; Lipman MC; Johnson MA; Janossy G
AIDS; 1994 Apr; 8(4):431-41. PubMed ID: 8011246
[TBL] [Abstract][Full Text] [Related]
8. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1.
Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614
[TBL] [Abstract][Full Text] [Related]
9. T cell activation and disease severity in HIV infection.
Mahalingam M; Peakman M; Davies ET; Pozniak A; McManus TJ; Vergani D
Clin Exp Immunol; 1993 Sep; 93(3):337-43. PubMed ID: 8103715
[TBL] [Abstract][Full Text] [Related]
10. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years.
Arnó A; Ruiz L; Juan M; Zayat MK; Puig T; Balagué M; Romeu J; Pujol R; O'Brien WA; Clotet B
AIDS; 1998 May; 12(7):697-704. PubMed ID: 9619800
[TBL] [Abstract][Full Text] [Related]
11. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
12. Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART.
Tanaskovic S; Fernandez S; Saraswati H; Yunihastuti E; Gani RA; Djauzi S; Price P
Viral Immunol; 2016 Apr; 29(3):176-83. PubMed ID: 27035638
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2.
Borrione P; Montacchini L; Beggiato E; Pileri A; Bianchi A; Massaia M
Leuk Lymphoma; 1996 Apr; 21(3-4):325-30. PubMed ID: 8726415
[TBL] [Abstract][Full Text] [Related]
14. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
[TBL] [Abstract][Full Text] [Related]
15. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
Bisset LR; Cone RW; Huber W; Battegay M; Vernazza PL; Weber R; Grob PJ; Opravil M
AIDS; 1998 Nov; 12(16):2115-23. PubMed ID: 9833852
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity.
Watret KC; Whitelaw JA; Froebel KS; Bird AG
Clin Exp Immunol; 1993 Apr; 92(1):93-9. PubMed ID: 7682164
[TBL] [Abstract][Full Text] [Related]
17. Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infection.
Jariwalla RJ; Lalezari J; Cenko D; Mansour SE; Kumar A; Gangapurkar B; Nakamura D
J Altern Complement Med; 2008 Mar; 14(2):139-46. PubMed ID: 18315507
[TBL] [Abstract][Full Text] [Related]
18. The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects.
Grant MD; Smaill FM; Singal DP; Rosenthal KL
AIDS; 1992 Oct; 6(10):1085-94. PubMed ID: 1361339
[TBL] [Abstract][Full Text] [Related]
19. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
[TBL] [Abstract][Full Text] [Related]
20. Changes of blood CD16/CD56 (NK) and HLA-DR/CD3-positive lymphocyte amounts in HIV-infected children, as related to clinical progression and p24-antigen/p24-antibody presence.
Voiculescu C; Avramescu C; Balasoiu M; Turculeanu A; Radu E
FEMS Immunol Med Microbiol; 1994 Sep; 9(3):217-21. PubMed ID: 7529081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
